Editas Medicine (EDIT) Earnings Date, Estimates & Call Transcripts $1.54 -0.10 (-6.10%) Closing price 05/5/2025 04:00 PM EasternExtended Trading$1.54 -0.01 (-0.32%) As of 04:17 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Editas Medicine Earnings Summary Upcoming Earnings DateMay. 6EstimatedConsensus EPS (Mar. 5) -$0.39 Actual EPS (Mar. 5) -$0.55 Missed By -$0.16 Actual Revenue (Mar. 5) $30.60MEditas Medicine posted Q4 2024 earnings on March 5, 2025, reporting an EPS of -$0.55, which missed analysts' consensus estimates of -$0.39 by $0.16. Quarterly revenue was reported to be $30.60 million, below analyst estimates of $37.17 million. With a trailing EPS of -$2.88, Editas Medicine's earnings are expected to grow next year, from ($2.71) to ($1.66) per share. Q4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)EDIT Upcoming EarningsEditas Medicine's Q1 2025 earnings is scheduled for Tuesday, May 6, 2025Powered by Get Editas Medicine Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Editas Medicine and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataEDIT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EDIT Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Editas Medicine Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.63-$0.46-$0.55Q2 20253-$0.66-$0.33-$0.44Q3 20253-$0.65-$0.14-$0.41Q4 20253-$0.68-$0.14-$0.34 FY 2025 12 -$2.62 -$1.07 -$1.73 Q1 20262-$0.63-$0.45-$0.54Q2 20262-$0.62-$0.39-$0.51Q3 20262-$0.61-$0.48-$0.55Q4 20262-$0.60-$0.18-$0.39 Editas Medicine Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)--------3/5/2025Q4 2024-$0.39-$0.55 -$0.16-$0.55$37.17M$30.60M11/4/2024Q3 2024-$0.75-$0.75--$0.75$3.93M$0.06M8/7/2024Q2 2024-$0.70-$0.82 -$0.12-$0.82$4.78M$0.51M5/8/2024Q1 2024-$0.63-$0.76 -$0.13-$0.76$11.14M$1.10M2/28/2024Q4 2023-$0.52-$0.23+$0.29-$0.23$4.84M$60.00M11/3/2023Q3 2023-$0.64-$0.55+$0.09-$0.55$3.70M$5.34M8/2/2023Q2 2023-$0.76-$0.56+$0.20-$0.56$4.17M$2.89M Editas Medicine Earnings - Frequently Asked Questions When is Editas Medicine's earnings date? Editas Medicine has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on EDIT's earnings history. Did Editas Medicine beat their earnings estimates last quarter? In the previous quarter, Editas Medicine (NASDAQ:EDIT) missed the analysts' consensus estimate of ($0.39) by $0.16 with a reported earnings per share (EPS) of ($0.55). Learn more on analysts' earnings estimate vs. EDIT's actual earnings. How much revenue does Editas Medicine generate each year? Editas Medicine (NASDAQ:EDIT) has a recorded annual revenue of $32.31 million. How much profit does Editas Medicine generate each year? Editas Medicine (NASDAQ:EDIT) has a recorded net income of -$153.22 million. EDIT has generated -$2.88 earnings per share over the last four quarters. What is Editas Medicine's EPS forecast for next year? Editas Medicine's earnings are expected to grow from ($2.71) per share to ($1.66) per share in the next year. More Earnings Resources from MarketBeat Related Companies Kura Oncology Earnings Results UroGen Pharma Earnings Results Stoke Therapeutics Earnings Results Verve Therapeutics Earnings Results Upstream Bio Earnings Results Mind Medicine (MindMed) Earnings Results GH Research Earnings Results Sage Therapeutics Earnings Results REGENXBIO Earnings Results Cullinan Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Is Reddit Stock a Buy, Sell, or Hold After Earnings Release?Warning or Opportunity After Super Micro Computer's EarningsAmazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousRocket Lab Braces for Q1 Earnings Amid Soaring ExpectationsMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernVisa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan This page (NASDAQ:EDIT) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Editas Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Editas Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy EDIT Stock Free EDIT Stock Alerts